LYEL · Lyell Immunopharma, Inc. · Documents
$9.31
-0.08 (-0.85%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$228.14M
Shares
24.51M
Volume · Oct 26
85.22K
Avg daily vol (3M)
152.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| 8-K | — | 2026-09-10 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-06 | — | |
| S-3 | — | 2026-07-13 | — | |
| 8-K | — | 2026-06-15 | 2026-06-10 | |
| Investor Event Transcript | — | 2026-06-08 | 2026-06-30 | |
| 8-K | — | 2026-05-06 | — | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| DEF 14A | — | 2026-04-24 | 2026-06-10 | |
| DEFA14A | — | 2026-04-24 | — | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| S-3 | — | 2026-04-03 | — | |
| 8-K | — | 2026-03-12 | — | |
| 10-K | — | 2026-03-12 | 2025-12-31 | |
| 8-K | — | 2026-03-09 | 2026-03-06 | |
| 8-K | — | 2025-12-08 | 2025-12-07 | |
| S-3 | — | 2025-12-05 | — | |
| 8-K | — | 2025-12-05 | 2025-12-03 | |
| 8-K | — | 2025-11-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | 2025-11-06 | |
| 8-K | — | 2025-11-03 | 2025-10-31 | |
| 8-K | — | 2025-09-16 | 2025-09-15 | |
| S-3 | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-07-25 | 2025-07-24 | |
| S-3 | — | 2025-07-18 | — | |
| 8-K | — | 2025-06-26 | 2025-06-20 | |
| 8-K | — | 2025-06-17 | — | |
| 8-K | — | 2025-06-09 | — | |
| 8-K | — | 2025-05-28 | 2025-05-27 | |
| 8-K | — | 2025-05-21 | 2025-05-15 | |
| 8-K | — | 2025-05-13 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| ARS | — | 2025-04-21 | 2024-12-31 | |
| DEF 14A | — | 2025-04-21 | 2025-05-15 | |
| PRE 14A | — | 2025-04-10 | 2025-05-15 | |
| 8-K | — | 2025-04-01 | 2025-03-27 | |
| 8-K | — | 2025-03-11 | — | |
| 10-K | — | 2025-03-11 | 2024-12-31 | |
| 8-K | — | 2025-01-24 | 2025-01-23 | |
| 8-K/A | — | 2025-01-10 | 2024-10-31 | |
| 8-K | — | 2024-12-10 | 2024-12-09 | |
| S-3 | — | 2024-11-29 | — | |
| 8-K | — | 2024-11-26 | 2024-11-22 | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-11-07 | — | |
| 8-K | — | 2024-10-31 | — |
Showing 1–50 of 104 filings
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
12 filings
12 filers
Visit website
Investor relations